Hometown: Orlando, FL
Undergrad: University of Florida
Grad: Columbia University
Medical School: Loyola University Chicago
Favorite Case in Urology: anything involving the use of fun gadgets and gizmos
Favorite OR music: Pop, Jazz, Rock, Country, Hip Hop, R&B, Rap, Classical, Show Tunes, holiday music, international music ... did I miss any ;)
Fun Fact: I've traveled to over 100 countries.
Medical School: Medical College of Georgia
Residency: Medical College of Georgia
Clinical Interests: Kidney stones,Endourology,Elevated PSA, Men’s Health and Vasectomy
Dr Oliver is an Assistant Clinical Professor with Vanderbilt Urology. He has 30 years of office-based urology experience and is currently serving the newly acquired Vanderbilt Wilson County Hospital in Lebanon.
Undergrad: Murray State University
Nursing School: University at Alabama at Birmingham
Clinical Interests: Pediatric Urology
Undergrad: Tennessee Technological University
Nursing School: Vanderbilt University School of Nursing
Clinical Interests: Pediatric Urology
Undergrad: Furman University
Nursing School: Vanderbilt University School of Nursing
Fellowship: Vanderbilt Urology NP Fellowship
Clinical Interests: Prostate Cancer, Bladder Cancer, Kidney Cancer, Genitourinary Cancer, Testis Cancer
Dr. Joyce offers the full spectrum of contemporary urologic oncology surgery, including advanced robotic, single-port robotic and complex open surgical procedures for kidney, testicular, bladder, prostate and adrenal genitourinary malignancies.
His practice is particularly focused on kidney and testicular cancers, especially highly complex cases requiring advanced surgical planning and multidisciplinary care. He performs cutting-edge, minimally invasive procedures such as single-port robotic partial nephrectomy while also maintaining expertise in major open oncologic operations, including retroperitoneal lymph node dissection and inferior vena cava tumor thrombus surgery for advanced renal cell carcinoma. Patients are frequently referred to him for technically challenging kidney masses, advanced testicular cancer and locally advanced genitourinary malignancies.
In addition to his surgical practice, Dr. Joyce is an active health services and outcomes researcher whose work focuses on improving the value of cancer care, reducing financial toxicity for patients and integrating patient-reported outcomes into clinical decision-making. His research has examined comparative effectiveness, healthcare policy, cost-effectiveness of cancer therapies and shared decision-making in urologic oncology. He has authored numerous peer-reviewed publications and national presentations related to health care value, cancer outcomes, health care economics and patient-centered cancer care.
Dr. Joyce maintains an active national presence in academic urology and health care policy discussions, contributing to initiatives focused on improving cancer care delivery, transparency and physician-patient communication. His work seeks to combine surgical excellence, patient-centered care, health care economics and emerging technologies to improve outcomes and decision-making for patients with genitourinary cancers.
Medical School: Mayo Medical School
Residency: Vanderbilt University Medical Center
Fellowship: Mayo Clinic, Rochester MN
Clinical Interests: Kidney Cancer, Testis Cancer, Bladder Cancer, Prostate cancer, Genitourinary cancer
Dr. Joyce is a urologic oncologist and assistant professor in the Department of Urology at Vanderbilt University Medical Center specializing in the surgical management of complex genitourinary cancers. He completed a Society of Urologic Oncology fellowship and earned a master’s degree with a concentration in healthcare delivery at the Mayo Clinic in Rochester, Minn., where he also attended medical school. He received a Bachelor of Fine Arts with honors from New York University and completed his urology residency at Vanderbilt University Medical Center. He is a member of the Alpha Omega Alpha Honor Medical Society and has held multiple national leadership roles, including service on the Society of Urologic Oncology Fellowship Committee, the American Urological Association Southeastern Section Bylaws Committee, and the National Comprehensive Cancer Network Testicular Cancer Guidelines Panel. He previously served as an editor for The Journal of Urology and as the Southeastern Section representative for the American Urological Association Residents and Fellows Committee.
Medical Degree: State University of New York at Buffalo
Residency: University of Michigan
Fellowship: Vanderbilt University Medical Center
Clinical Interests: Bladder Cancer, Kidney Cancer, Prostate Cancer, Testis Cancer, Urologic Cancer
Dr. Luckenbaugh is a high-volume surgeon whose clinical focus centers around the comprehensive care of patients with urologic malignancies. She currently serves as the chair of Women in Urologic Oncology, and the President for the Society of Women in Urology, and through her research aims to mitigate variation in healthcare delivery.